647
Participants
Start Date
November 30, 2008
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Levonorgestrel (Mirena, BAY86-5028)
Women using Mirena for treatment of menorrhagia
Conventional medical treatment
Women using combined oral contraceptives, oral/injectable progestogens, non-steroidal anti-inflammatory drug
Conventional medical treatment
Women using anti-fibrinolytic agent for treatment of menorrhagia
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Lead Sponsor
Bayer
INDUSTRY